1.McFarland, LV. Diarrhea acquired in the hospital. Gastroenterol Clin N Am 1993;22:563–577.
2.Morris, AM, Jobe, BA, Stoney, M, Sheppard, BC, Deveney, CW, Deveney, KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096–1100.
3.Archibald, LK, Banerjee, SN, Jarvis, WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585–1589.
4.Dallal, RM, Harbrecht, BG, Goujoukas, AJ, et al.Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363–372.
5.McDonald, LC, Owings, M, Jernigan, DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Diseases 2006;12:409–415.
6.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.
7.McDonald, LC, Killgore, GE, Thompson, A, et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–2441.
8.Boyce, JM, Havill, NL, McDonald, LC, et al.An outbreak of severe Clostridium difficile-associated disease involving an epidemic strain with increased virulence. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 9-12, 2005; Los Angeles, CA. Abstract 59.
9.Mulligan, ME, George, WL, Rolfe, RD, Finegold, SM. Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis. Am J Clin Nutr 1980;33:2533–2538.
10.Fekety, R, Kim, K-H, Brown, D, Batts, DH, Cudmore, M, Silva, J Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med 1981;70:906–908.
11.Samore, MH, Venkataraman, L, Degirolami, PC, Levin, E, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32–40.
12.Johnston, MD, Lawson, S, Otter, JA. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005;60:403–411.
13.French, GL, Otter, JA, Shannon, KP, Adams, NMT, Watling, D, Parks, MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004;57:31–37.
14.Dubberke, ER, Reske, KA, Noble-Wang, J, et al.Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Cont 2007;35:315–318.
15.NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.
16.World Health Organization (WHO). Anatomical therapeutic chemical (ATC) classification index with defined daily doses (DDD). Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2004.
17.Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.
18.Simor, AE, Bradley, SF, Strausbaugh, LJ, Crossley, K, Nicolle, LE, SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23:696–703.
19.Johnson, S, Gerding, DN, Olson, MM, et al.Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88:137–140.
20.Rutala, WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 1996;24:313–342.
21.Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000;31:995–1000.
22.Worsley, MA. Infection control and prevention of Clostridium difficile infection. J Antimicrob Chemother 1998;41(Suppl C):59–66.
23.Sehulster, L, Chinn, RY, CDC, HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003;52(RR-10):1–42.
24.Rutala, WA, Weber D, J. Use of inorganic hypochlorite (bleach) in healthcare facilities. Clin Microbiol Rev 1997;10:597–610.
25.Larson, HE, Barclay, FE, Honour, P, Hill, ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727–733.
26.Wilcox, MH, Settle, C, Parnell, P, Porter, C, Keer, V, Hawkey, P. Isolation of patients with Clostridium difficile infection. J Hosp Infect 1997;37:331–343.
27.McFarland, LV, Mulligan, ME, Kwok, RYY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204–210.
28.Kaatz, GW, Gitlin, SD, Schaberg, DR, et al.Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289–1294.
29.Struelens, MJ, Maas, A, Nonhoff, C, et al.Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991;91(Suppl 3B):138–144.
30.Fawley, WN, Wilcox, MH. Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect 2001;126:343–350.
31.Savage, AM, Alford, RH. Nosocomial spread of Clostridium difficile. Infect Control 1983;4:31–33.
32.McFarland, LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995;23:295–305.
33.Brooks, SE, Veal, RO, Kramer, M, Dore, L, Schupf, N, Adachi, M. Reduction in the incidence of Clostridium difficile associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992;13:98–103.
34.Jernigan, JA, Siegman-Igra, Y, Guerrant, RC, Farr, BM. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 1998;19:494–499.
35.Bhalla, A, Pultz, NJ, Gries, DM, et al.Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004;25:164–167.
36.Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003;54:109–114.
37.Apisarnthanarak, A, Zack, JE, Mayfield, JL, et al.Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis 2004;39:601–602.
38.Otter, JA, Cummins, M, Ahmad, F, van Tonder, C, Drabu, YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67:182–188.
39.Bates, CJ, Pearse, R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 2006;61:364–366.
40.Otter, JA, French, GL, Adams, NMT, Watling, D, Parks, MJ. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006;62:384–392.